GCM2 and breast carcinoma: For example, hypermethylated circulating glial cells missing transcription factor 2 (GCM2) has been reported as a noninvasive breast cancer-specific biomarker in both TCGA data and Taiwanese breast cancer patients, across all major breast cancer subtypes [20].